Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD-Reference-Cited by-同舟云学术

Bronchodilators delivered by nebuliser versus pMDI with spacer or DPI for exacerbations of COPD

Published:2016-08-29 Issue:8 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

van Geffen Wouter H¹²,Douma W R¹,Slebos Dirk Jan¹,Kerstjens Huib AM¹

Affiliation:

1. University of Groningen, University Medical Center Groningen; Department of Pulmonary Diseases and Tuberculosis; Hanzeplein 1 Groningen Netherlands 9713 GZ

2. Medical Center Leeuwarden; Department of Pulmonary Diseases; Henri Dunantweg 2 Leeuwarden Netherlands 8934 AD

Publisher

Wiley

Subject

Pharmacology (medical)

Reference75 articles.

1. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD;Berry;Chest,1989

2. Changes in blood gas levels after nebuhaler and nebulizer administration of terbutaline in severe chronic airway obstruction;Higgins;Bulletin Européen de Physiopathologie Respiratoire,1987

3. Comparison of a hand-held nebulizer with a metered dose inhaler-spacer combination in acute obstructive pulmonary disease;Maguire;Chest,1991

4. Relative lung deposition of salbutamol following inhalation from a spacer and a Sidestream jet nebulizer following an acute exacerbation;Mazhar;British Journal of Clinical Pharmacology,2008

5. Comparison of cost-effectiveness of bronchodilator drugs via inhaler or nebulizer route in exacerbations of chronic obstructive pulmonary disease;Mirici;Turkish Respiratory Journal,2004

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exazerbationen bei COPD: sicher beurteilen, adäquat behandeln;Pneumo News;2024-06-27

2. Successful Use of Easyhaler® Dry Powder Inhaler in Patients with Chronic Obstructive Pulmonary Disease; Analysis of Peak Inspiratory Flow from Three Clinical Trials;Pulmonary Therapy;2024-01-03

3. Real-World Use of Inhaled COPD Medications: the Good, the Bad, the Ugly;Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation;2024

4. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease;Cochrane Database of Systematic Reviews;2023-12-06

5. Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease;American Journal of Respiratory and Critical Care Medicine;2023-11-15